OBI vs. HZD, VRP, FARN, ARIX, BVXP, AVCT, 4BB, CIR, HVO, and TILS
Should you be buying Ondine Biomedical stock or one of its competitors? The main competitors of Ondine Biomedical include Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Faron Pharmaceuticals Oy (FARN), Arix Bioscience (ARIX), Bioventix (BVXP), Avacta Group (AVCT), 4basebio (4BB), Circassia Group (CIR), hVIVO (HVO), and Tiziana Life Sciences (TILS). These companies are all part of the "biotechnology" industry.
Ondine Biomedical vs.
Ondine Biomedical (LON:OBI) and Horizon Discovery Group plc (HZD.L) (LON:HZD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, community ranking, media sentiment, dividends, risk, profitability and institutional ownership.
20.6% of Ondine Biomedical shares are held by institutional investors. 36.7% of Ondine Biomedical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Horizon Discovery Group plc (HZD.L) received 460 more outperform votes than Ondine Biomedical when rated by MarketBeat users. However, 100.00% of users gave Ondine Biomedical an outperform vote while only 73.52% of users gave Horizon Discovery Group plc (HZD.L) an outperform vote.
Horizon Discovery Group plc (HZD.L) has a net margin of 0.00% compared to Ondine Biomedical's net margin of -873.84%. Horizon Discovery Group plc (HZD.L)'s return on equity of 0.00% beat Ondine Biomedical's return on equity.
In the previous week, Ondine Biomedical had 1 more articles in the media than Horizon Discovery Group plc (HZD.L). MarketBeat recorded 1 mentions for Ondine Biomedical and 0 mentions for Horizon Discovery Group plc (HZD.L). Ondine Biomedical's average media sentiment score of 0.00 equaled Horizon Discovery Group plc (HZD.L)'saverage media sentiment score.
Horizon Discovery Group plc (HZD.L) has higher revenue and earnings than Ondine Biomedical. Ondine Biomedical is trading at a lower price-to-earnings ratio than Horizon Discovery Group plc (HZD.L), indicating that it is currently the more affordable of the two stocks.
Summary
Ondine Biomedical beats Horizon Discovery Group plc (HZD.L) on 6 of the 11 factors compared between the two stocks.
Get Ondine Biomedical News Delivered to You Automatically
Sign up to receive the latest news and ratings for OBI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ondine Biomedical Competitors List
Related Companies and Tools
This page (LON:OBI) was last updated on 2/22/2025 by MarketBeat.com Staff
